Xiaotian Xia

780 total citations
67 papers, 508 citations indexed

About

Xiaotian Xia is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaotian Xia has authored 67 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaotian Xia's work include Nanoplatforms for cancer theranostics (7 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Xiaotian Xia is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Xiaotian Xia collaborates with scholars based in China, United States and Iran. Xiaotian Xia's co-authors include Xiaoli Lan, Yongxue Zhang, Chunxia Qin, Minggao Guo, Wenfei Liu, Hongyan Feng, Chongjiao Li, Peipei Xu, Hui Yuan and Yongkang Gai and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Membrane Science.

In The Last Decade

Xiaotian Xia

58 papers receiving 505 citations

Peers

Xiaotian Xia

RNMI

ONCOL

PRM

Zairong Gao China

Chunjing Yu China

Wendy Wong Singapore

Xiaona Jin China

Chuan Peng China

Fang Nie China

Shundong Ji China

Yuzhen Yin China

Wentao Kong China

Yiwei Wu China

Zairong Gao China

Xiaotian Xia

122 ×0.7

RNMI

122 ×0.9

67 ×0.5

ONCOL

51 ×0.5

100 ×1.3

PRM

Citations per year, relative to Xiaotian Xia Xiaotian Xia (= 1×) peers Zairong Gao

Countries citing papers authored by Xiaotian Xia

Since Specialization

Citations

This map shows the geographic impact of Xiaotian Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotian Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotian Xia more than expected).

Fields of papers citing papers by Xiaotian Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaotian Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotian Xia. The network helps show where Xiaotian Xia may publish in the future.

Co-authorship network of co-authors of Xiaotian Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaotian Xia. A scholar is included among the top collaborators of Xiaotian Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaotian Xia. Xiaotian Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Ruiming, Ting Yao, Xiaoying Jiang, et al.. (2025). Precision scalpels for the epigenome: next-gen editing tools in targeted therapies. Frontiers in Medicine. 12. 1613722–1613722. 1 indexed citations

Xu, Xiaojun, Xun Sun, Ling Ma, et al.. (2023). 18F-FDG PET/CT radiomics signature and clinical parameters predict progression-free survival in breast cancer patients: A preliminary study. Frontiers in Oncology. 13. 1149791–1149791. 6 indexed citations

Rong, Jian, Chunyu Zhao, Xiaotian Xia, et al.. (2023). Evaluation of [18F]Favipiravir in Rodents and Nonhuman Primates (NHP) with Positron Emission Tomography. Pharmaceuticals. 16(4). 524–524. 4 indexed citations

Hu, Shengqing, Fuqiang Shao, Fan Hu, et al.. (2023). Occurrence of parathyroid carcinoma following parathyroid adenoma resection. Quantitative Imaging in Medicine and Surgery. 13(5). 3371–3377.

Wang, Keshan, Yongkang Gai, Mengting Li, et al.. (2023). Nanomedicine for renal cell carcinoma: imaging, treatment and beyond. Journal of Nanobiotechnology. 21(1). 3–3. 19 indexed citations

Yu, Long, Fuqiang Shao, Hao Ji, et al.. (2022). Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 49(12). 4156–4170. 2 indexed citations

Yu, Long, Hao Ji, Qingyao Liu, et al.. (2022). Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging. Pharmaceutics. 14(9). 1791–1791. 14 indexed citations

Liu, Wenfei, et al.. (2022). Development of a joint diagnostic model of thyroid papillary carcinoma with artificial neural network and random forest. Frontiers in Genetics. 13. 957718–957718. 2 indexed citations

Liu, Wenfei, et al.. (2022). A Proposed Heterogeneous Ensemble Algorithm Model for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer. International Journal of General Medicine. Volume 15. 4717–4732. 12 indexed citations

10.

Yu, Long, Fuqiang Shao, Hao Ji, et al.. (2022). Evaluation of a CD13 and Integrin αvβ3 Dual-Receptor Targeted Tracer 68Ga-NGR-RGD for Ovarian Tumor Imaging: Comparison With 18F-FDG. Frontiers in Oncology. 12. 884554–884554. 9 indexed citations

11.

Haider, Ahmed, Zhiwei Xiao, Xiaotian Xia, et al.. (2021). Development of a triazolobenzodiazepine-based PET probe for subtype-selective vasopressin 1A receptor imaging. Pharmacological Research. 173. 105886–105886. 2 indexed citations

12.

Liu, Wenfei, et al.. (2021). Risk Factor Analysis for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma. International Journal of General Medicine. Volume 14. 9923–9929. 11 indexed citations

13.

Zeng, Su, et al.. (2021). The Strategy of Conditionally Replicating Adenovirus-Mediated PreS2 Mini-Antibody Expression Has Dual Effects of Inhibiting HBV Infection and Preventing Hepatocellular Carcinoma. Cancer Management and Research. Volume 13. 1869–1876. 1 indexed citations

14.

Han, Yan, Yingying Wu, Zhaodong Zhong, et al.. (2021). Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Oncology. 11. 626018–626018. 1 indexed citations

15.

Xia, Xiaotian, Fuqiang Shao, Fan Hu, Yongkang Gai, & Xiaoli Lan. (2020). Culprit Tumor as an Unexpected Extraosseous MDP Activity on Bone Scintigraphy in a Patient With Tumor-Induced Osteomalacia. Clinical Nuclear Medicine. 45(6). 492–494. 1 indexed citations

16.

Xia, Xiaotian, et al.. (2018). Parathyroid cysts: experience of a rare phenomenon at a single institution. BMC Surgery. 18(1). 9–9. 7 indexed citations

17.

Zhang, Yingying, Yongxue Zhang, Xiaotian Xia, et al.. (2017). Synthesis and Bioevaluation of Iodine-131 Directly Labeled Cyclic RGD-PEGylated Gold Nanorods for Tumor-Targeted Imaging. Contrast Media & Molecular Imaging. 2017. 1–10. 31 indexed citations

18.

Li, Chongjiao, Bing Wen, Lifei Wang, et al.. (2015). 99mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor. Nuclear Medicine Communications. 36(5). 452–460. 8 indexed citations

19.

Feng, Hongyan, Xiaotian Xia, Chongjiao Li, et al.. (2015). TYR as a multifunctional reporter gene regulated by the Tet-on system for multimodality imaging: an in vitro study. Scientific Reports. 5(1). 15502–15502. 14 indexed citations

20.

Pei, Zhi‐Jun, Xiaoli Lan, Zhen Cheng, et al.. (2014). Multimodality Molecular Imaging to Monitor Transplanted Stem Cells for the Treatment of Ischemic Heart Disease. PLoS ONE. 9(3). e90543–e90543. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact